Shu Xie

419 total citations
6 papers, 351 citations indexed

About

Shu Xie is a scholar working on Cognitive Neuroscience, Cellular and Molecular Neuroscience and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Shu Xie has authored 6 papers receiving a total of 351 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Cognitive Neuroscience, 2 papers in Cellular and Molecular Neuroscience and 2 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Shu Xie's work include Autism Spectrum Disorder Research (3 papers), Diabetes Treatment and Management (2 papers) and Neuropeptides and Animal Physiology (2 papers). Shu Xie is often cited by papers focused on Autism Spectrum Disorder Research (3 papers), Diabetes Treatment and Management (2 papers) and Neuropeptides and Animal Physiology (2 papers). Shu Xie collaborates with scholars based in China and South Korea. Shu Xie's co-authors include Wei Jing Liu, Tae Sun Park, Heung Yong Jin, Yi Ming Shao, Won Bae Kim, Yu Ning Liu, Kyung Ae Lee, Hong Sun Baek, Mingyang Zou and Luxi Wang and has published in prestigious journals such as Journal of Pharmacology and Experimental Therapeutics, British Journal of Pharmacology and Frontiers in Psychiatry.

In The Last Decade

Shu Xie

6 papers receiving 344 citations

Peers

Shu Xie

EDM

ONCOL

SURGE

MB

CMN

Laura L. Souza Brazil

Damien Bergerot France

Haruki Fujisawa Japan

Phebe Wilson United States

Teresa Procopio Italy

Miriam Lettieri United Kingdom

Gillian Brooker United Kingdom

Anne Mette Strand Denmark

Ann Maria Kruse Hansen Denmark

L.‐O. Farnebo Sweden

Laura L. Souza Brazil

Shu Xie

69 ×0.4

EDM

27 ×0.3

ONCOL

39 ×0.6

SURGE

137 ×2.0

MB

109 ×1.7

CMN

Citations per year, relative to Shu Xie Shu Xie (= 1×) peers Laura L. Souza

Countries citing papers authored by Shu Xie

Since Specialization

Citations

This map shows the geographic impact of Shu Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shu Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shu Xie more than expected).

Fields of papers citing papers by Shu Xie

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shu Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shu Xie. The network helps show where Shu Xie may publish in the future.

Co-authorship network of co-authors of Shu Xie

This figure shows the co-authorship network connecting the top 25 collaborators of Shu Xie. A scholar is included among the top collaborators of Shu Xie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shu Xie. Shu Xie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Zou, Mingyang, Yu Liu, Shu Xie, et al.. (2021). Alterations of the endocannabinoid system and its therapeutic potential in autism spectrum disorder. Open Biology. 11(2). 200306–200306. 34 indexed citations

2.

Liu, Yu, Luxi Wang, Shu Xie, et al.. (2021). Attention Deficit/Hyperactivity Disorder Symptoms Impair Adaptive and Social Function in Children With Autism Spectrum Disorder. Frontiers in Psychiatry. 12. 654485–654485. 10 indexed citations

3.

Zou, Mingyang, Dexin Li, Luxi Wang, et al.. (2020). Identification of Amino Acid Dysregulation as a Potential Biomarker for Autism Spectrum Disorder in China. Neurotoxicity Research. 38(4). 992–1000. 11 indexed citations

4.

Liu, Yuning, Jingwei Zhou, Tingting Li, et al.. (2017). Sulodexide Protects Renal Tubular Epithelial Cells from Oxidative Stress-Induced Injury via Upregulating Klotho Expression at an Early Stage of Diabetic Kidney Disease. Journal of Diabetes Research. 2017. 1–10. 34 indexed citations

5.

Liu, Wei Jing, Shu Xie, Yu Ning Liu, et al.. (2011). Dipeptidyl Peptidase IV Inhibitor Attenuates Kidney Injury in Streptozotocin-Induced Diabetic Rats. Journal of Pharmacology and Experimental Therapeutics. 340(2). 248–255. 190 indexed citations

6.

Liu, Wei Jing, Heung Yong Jin, Kyung Ae Lee, et al.. (2011). Neuroprotective effect of the glucagon-like peptide-1 receptor agonist, synthetic exendin-4, in streptozotocin-induced diabetic rats. British Journal of Pharmacology. 164(5). 1410–1420. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact